6368 related articles for article (PubMed ID: 3257967)
61. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
Cohen RL; Niclas J; Lee WM; Wun TC; Crowley CW; Levinson AD; Sadler JE; Shuman MA
J Biol Chem; 1989 May; 264(14):8375-83. PubMed ID: 2498314
[TBL] [Abstract][Full Text] [Related]
62. Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma.
Wiman B; Lindahl T; Almqvist A
Thromb Haemost; 1988 Jun; 59(3):392-5. PubMed ID: 3142076
[TBL] [Abstract][Full Text] [Related]
63. Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells.
Levin EG; Santell L
Blood; 1987 Oct; 70(4):1090-8. PubMed ID: 3498518
[TBL] [Abstract][Full Text] [Related]
64. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta.
Philips M; Juul AG; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1986 Apr; 55(2):213-7. PubMed ID: 2424117
[TBL] [Abstract][Full Text] [Related]
65. PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines--evidence that the liver contributes to acute phase behaviour of PAI-1.
de Boer JP; Abbink JJ; Brouwer MC; Meijer C; Roem D; Voorn GP; Lambers JW; van Mourik JA; Hack CE
Thromb Haemost; 1991 Feb; 65(2):181-5. PubMed ID: 1711245
[TBL] [Abstract][Full Text] [Related]
66. Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin.
Seiffert D; Mimuro J; Schleef RR; Loskutoff DJ
Cell Differ Dev; 1990 Dec; 32(3):287-92. PubMed ID: 1711915
[TBL] [Abstract][Full Text] [Related]
67. Treatment of mouse L-cells with phorbol myristate acetate induces the secretion of a plasminogen activator inhibitor which binds to human and mouse urokinase and human tissue plasminogen activator.
Rehemtulla A; Gates J; Hart DA
Comp Biochem Physiol B; 1987; 88(1):277-83. PubMed ID: 3119281
[TBL] [Abstract][Full Text] [Related]
68. Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors.
Schleef RR; Loskutoff DJ
Haemostasis; 1988; 18(4-6):328-41. PubMed ID: 3148526
[TBL] [Abstract][Full Text] [Related]
69. Immunological relationship between plasminogen activator inhibitors from different sources.
Urdén G; Chmielewska J; Carlsson T; Wiman B
Thromb Haemost; 1987 Feb; 57(1):29-34. PubMed ID: 2438797
[TBL] [Abstract][Full Text] [Related]
70. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.
Niiya K; Nsimba M; Hayashi T; Sakuragawa N
Thromb Res; 1992 Feb; 65(3):311-21. PubMed ID: 1631798
[TBL] [Abstract][Full Text] [Related]
71. Endotoxin-induced secretion of an active plasminogen activator inhibitor from bovine pulmonary arterial and aortic endothelial cells.
Crutchley DJ; Conanan LB; Ryan US
Biochem Biophys Res Commun; 1987 Nov; 148(3):1346-53. PubMed ID: 3120714
[TBL] [Abstract][Full Text] [Related]
72. Enzyme secretion by human endothelial cells infected with Rickettsia conorii.
Raoult D; Drancourt AM; Ardissone JP
Acta Virol; 1987 Aug; 31(4):352-6. PubMed ID: 2892385
[TBL] [Abstract][Full Text] [Related]
73. Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
Benjamin LA; McGarry RC; Hart DA
Cancer Chemother Pharmacol; 1989; 25(1):25-31. PubMed ID: 2590998
[TBL] [Abstract][Full Text] [Related]
74. An assay system for the modulators of plasminogen activation on the cell surface.
Osada H; Yamada C; Miwa K; Kono T; Oh-hira M
Thromb Res; 1991 Jun; 62(5):519-30. PubMed ID: 1896967
[TBL] [Abstract][Full Text] [Related]
75. Comparison of fibrinolytic activities of human and bovine endothelial cells.
Bartha K; Wojta J; Wagner OF; Binder BR
Am J Physiol; 1988 Jun; 254(6 Pt 2):R885-90. PubMed ID: 3132861
[TBL] [Abstract][Full Text] [Related]
76. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.
Schleef RR; Loskutoff DJ; Podor TJ
J Cell Biol; 1991 Jun; 113(6):1413-23. PubMed ID: 2045419
[TBL] [Abstract][Full Text] [Related]
77. Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1).
Alessi MC; Declerck PJ; De Mol M; Nelles L; Collen D
Eur J Biochem; 1988 Aug; 175(3):531-40. PubMed ID: 3261688
[TBL] [Abstract][Full Text] [Related]
78. [Regulatory mechanisms of PAI-1 on fibrinolysis in vascular endothelial cells].
Sakata Y
Rinsho Byori; 1989 Apr; Spec No 81():149-55. PubMed ID: 2502640
[No Abstract] [Full Text] [Related]
79. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
Hekman CM; Loskutoff DJ
J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
[TBL] [Abstract][Full Text] [Related]
80. Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibitor secretion by phorbol myristate acetate.
Hart DA; Smith R
Cancer Lett; 1987 Apr; 35(1):27-38. PubMed ID: 3105864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
